Genmab A/S (VIE:GMAB)
Austria · Delayed Price · Currency is EUR 284.20
+5.70 (2.05%)
At close: Dec 23, 2025
Genmab Revenue
Genmab had revenue of $1.02B USD in the quarter ending September 30, 2025, with 25.25% growth. This brings the company's revenue in the last twelve months to $3.47B, up 16.96% year-over-year. In the year 2024, Genmab had annual revenue of $3.00B with 23.13% growth.
Revenue (ttm)
$3.47B
Revenue Growth
+16.96%
P/S Ratio
5.34
Revenue / Employee
$1.29M
Employees
2,682
Market Cap
17.51B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.00B | 564.17M | 23.13% |
| Dec 31, 2023 | 2.44B | 351.45M | 16.83% |
| Dec 31, 2022 | 2.09B | 800.56M | 62.19% |
| Dec 31, 2021 | 1.29B | -372.56M | -22.45% |
| Dec 31, 2020 | 1.66B | 854.43M | 106.10% |
| Dec 31, 2019 | 805.32M | 340.75M | 73.35% |
| Dec 31, 2018 | 464.57M | 83.37M | 21.87% |
| Dec 31, 2017 | 381.20M | -144.81M | -27.53% |
| Dec 31, 2016 | 526.01M | 195.32M | 59.07% |
| Dec 31, 2015 | 330.68M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| OMV Aktiengesellschaft | 31.89B |
| Strabag SE | 17.92B |
| Voestalpine AG | 15.29B |
| Vienna Insurance Group AG | 13.13B |
| Erste Group Bank AG | 10.96B |
| Raiffeisen Bank International AG | 8.90B |
| VERBUND AG | 8.30B |
| Andritz AG | 7.84B |